androstenediol has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hackenberg, R; Schulz, KD | 1 |
| Adams, JB; Seymour-Munn, K | 1 |
1 review(s) available for androstenediol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenediol; Antineoplastic Agents, Hormonal; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoma; Carrier Proteins; Endometrial Neoplasms; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Pleural Effusion; Receptors, Androgen; Tumor Cells, Cultured | 1996 |
1 other study(ies) available for androstenediol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Estrogen receptor and C19-5-ene-steroid concentrations in the nuclear fraction from human breast carcinoma tissue.
Topics: Androstenediol; Androstenols; Breast Neoplasms; Carcinoma; Cell Nucleus; Dehydroepiandrosterone; Female; Humans; Menopause; Receptors, Estrogen | 1992 |